The Cohort Study of Early Esophageal Cancer or Precancerous Lesions Treated With Endoscopic Resection
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Early Esophageal Cancer or Precancerous Lesions Treated With Endoscopic Resection
- Sponsor
- Shanghai Zhongshan Hospital
- Enrollment
- 500
- Primary Endpoint
- Comparison WHO diagnosis standard with JAPAN in Early Esophageal Cancer patients by accessing pathological section.
- Last Updated
- 8 years ago
Overview
Brief Summary
Endoscopic Submucosal Dissection (ESD) is currently the main method of treatment of early esophageal cancer and precancerous lesions. Therefore, the investigators are looking forward to conduct a cohort study on early esophageal cancer patients undergoing endoscopic treatment collected from Zhongshan Hospital, Fudan University, comparing the WHO standard with Japanese standard of endoscopic therapy diagnosis. In addition，the investigators will collect patients' detailed informations and analyze the risk factors for metastasis and recurrence of early esophageal cancer.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Older than 15-year-old
- •Undergoing endoscopic Submucosal Dissection (ESD) in ZhongShan Hospital
Exclusion Criteria
- •Preoperative patients with recurrence and Lost to follow-up of patients within 1 year
Outcomes
Primary Outcomes
Comparison WHO diagnosis standard with JAPAN in Early Esophageal Cancer patients by accessing pathological section.
Time Frame: December 1st,2017-December 1st,2018
Comparison WHO diagnosis standard with JAPAN in Early Esophageal Cancer patients by accessing pathological section.